This is a working overview of PPARδ agonist, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
=== Epitope databases === MHCBN: A database of MHC/TAP binder and T-cell epitopes Bcipep: A database of B-cell epitopes SYFPEITHI — First online database of T cell epitopes IEDB — Database of T and B cell epitopes with annotation of recognition context — NIH funded ANTIJEN — T and B cell epitope database at the Jenner institute, UK IMGT/3Dstructure-DB — Three-dimensional structures of B and T cell epitopes with annotation of IG and TR — IMGT, Montpellier, France SEDB: A Structural Epitope Database — Pondicheery University, DIT funded Epitopes at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
The pancreatic islets or islets of Langerhans are the regions of the pancreas that contain its endocrine cells (hormone-producing cells), discovered in 1869 by German pathological anatomist Paul Langerhans. The pancreatic islets constitute 1–2% of the pancreas volume and receive 10–15% of its blood flow. The pancreatic islets are arranged in density routes throughout the human pancreas, and are important in the metabolism of glucose.
=== OECD Chief Economist === British economist Christopher Dow served as Chief Economist of the OECD from its establishment until 1973. In 1980, Canadian economist Sylvia Ostry became the first woman to be appointed OECD Chief Economist, holding the position until 1983. In 1992, Kumiharu Shigehara, former Chief Economist of the Bank of Japan, became the first individual from outside the English-speaking world to be appointed OECD Chief Economist. At the time of his appointment, the Financial Times, in an article entitled "Japan’s Turn" (22 January 1992), described him as exemplifying a new generation of Japanese figures characterised by self-confidence, strong international awareness, and a willingness to express their views openly. In February 2026, Italian Stefano Scarpetta was announced as the next Chief Economist. Scarpetta used to lead the Directorate's work on employment, migration and health.
Sources: en.wikipedia.org
Bush released his memoirs, Decision Points, on November 9, 2010. During a pre-release appearance promoting the book, Bush said he considered his biggest accomplishment to be keeping "the country safe amid a real danger", and his greatest failure to be his inability to secure the passage of Social Security reform. He also made news defending his administration's enhanced interrogation techniques, specifically the waterboarding of Khalid Sheikh Mohammed, saying, "I'd do it again to save lives." In 2012, he wrote the foreword to The 4% Solution: Unleashing the Economic Growth America Needs, an economics book published by the George W. Bush Presidential Center. He also presented the book at the Parkland Memorial Hospital in Dallas, Texas. Bush did not physically appear in that year's Republican National Convention (where Mitt Romney obtained the party's nomination for president), instead appearing in a videotape, in which he –alongside his father and immediate family– explained his reasons for supporting Romney. Bush appeared on NBC's The Tonight Show with Jay Leno on November 19, 2013, along with his wife Laura. When asked by Leno why he does not comment publicly about the Obama administration, Bush said: "I don't think it's good for the country to have a former president criticize his successor." Despite this statement, Bush vocally disagreed with Obama's withdrawal of U.S. troops from Iraq in 2011, calling it a "strategic blunder". In December, Bush traveled with President Obama to the memorial service of South African president and civil rights leader Nelson Mandela.
=== Re–Ru === Lynne Regan (Ph.D. 1987). British biochemist and biotechnologist at the University of Edinburgh which studies interactions between proteins and nucleic acids. Jens Reich (b. 1939). German biophysicist at the Central Institute of Molecular Biology of the Academy of Sciences in Berlin-Buch, pioneer in systems biology. Founder of the New Forum (civil rights movement). Jacques Ricard (1929–2018). French biochemist at the Institut Jacques Monod known for studies of plant enzymes and for developing the concept of enzyme memory. David Rittenberg (1906–1970). American biochemist at Columbia, a pioneer in the use of radioactive tracers to study metabolism. Member Natl. Acad. Sci. USA. Alexander Rich (1924–2015). American biophysicist at MIT, whose many contributions included elucidation of the structure of collagen (with Francis Crick). Member Natl. Acad. Sci. USA. Jane S. Richardson (b. 1941). American biophysicist at Duke University, known for the ribbon diagram, a method of representing the 3D structures of proteins. Member Natl. Acad. Sci. USA. Thorburn Brailsford Robertson (1884–1930), Australian physiologist and biochemist, known for promoting the use of insulin for diabetes in Australia. Dame Carol V. Robinson (b. 1956), British chemist and mass spectroscopist at the University of Oxford known for studies of protein folding. Robert G. Roeder (b. 1942), American biochemist, pioneer in eukaryotic transcription. Irwin Rose (1926–2015). American biochemist at the University of Pennsylvania, noted for the discovery of ubiquitin-mediated protein degradation.
=== Strontium unit: radiation dose === The strontium unit, formerly known as the Sunshine Unit (symbol S.U.), is a unit of biological contamination by radioactive substances (specifically strontium-90). It is equal to one picocurie of Sr-90 per gram of body calcium. Since about 2% of the human body mass is calcium, and Sr-90 has a half-life of 28.78 years, releasing 6.697+2.282 MeV per disintegration, this works out to about 1.065×10−12 grays per second. The permissible body burden was established at 1,000 S.U.
Sources: en.wikipedia.org
In 1945, the Vietnamese were locked in a struggle over the destiny of their post-colonial state after the ousting of the French and the surrender of Japan. Viet Minh forces seized control from the collapsing Empire of Vietnam, while the Vietnam Nationalist Party and Việt Cách advanced in Tonkin with the support of the Chinese Allied mission, and the Đại Việt Nationalist Party already posed serious competition to the Viet Minh. The South fractured between the Stalinist front Viet Minh and rival groups including the Trotskyists, Hòa Hảo, Cao Đài, and Bình Xuyên. The Indochinese Communist Party was primarily responsible for starting widespread Vietnamese-on-Vietnamese violence. Its Viet Minh front aimed to consolidate power through the terrorization and purging of the rival Vietnamese groups. In 1946, the Franco-Chinese and Ho–Sainteny Agreements enabled French forces to replace the Chinese north of the 16th parallel and facilitated a coexistence between the DRV and the French that strengthened the Viet Minh while undermining the nationalists. That summer, the Viet Minh colluded with French forces to eliminate nationalists, targeted for their ardent anti-colonialism. By eliminating the nationalist parties, the Viet Minh had undermined Vietnam's broader ability to resist French reconquest. The Bình Xuyên organized crime group also sought power in the country and although they initially fought alongside the Việt Minh, they would later support Bảo Đại.
In Tulsa, Jolene finds work as a receptionist and banquet server. She meets Brad Benton, the son of a wealthy family. He relentlessly pursues her, sending flowers to her workplace and charming her into dates. Outwardly religious but obnoxiously arrogant, he is rude, entitled, narcissistic and demanding to everyone. Brad pressures Jolene into quickly getting married and on their wedding night, he discovers a tattoo of a heart with flames on her backside, this triggers him and he anally rapes her. When Jolene becomes pregnant, Brad interrogates her on how many people she has had sex with; when she refuses to comply, he slaps her across the face. After their baby is born, Brad's parents investigate Jolene's past and inform him. He then brutally attacks her, permanently damaging her vocal cords. She tries to leave and take Brad Jr., but a domestic violence lawyer refuses to take her case due to her past. While staying in a shelter for battered women, the police come and arrest Jolene for kidnapping and Brad is granted an annulment. Jolene is convicted of the kidnapping and is allowed supervised visits. She decides to exit her baby's life while he is an infant, reasoning that he can imagine his mother to be anybody. Finally, Jolene ends up in Los Angeles, working as a comic illustrator for a graphic novel company, where she incorporates events from her life into her work. In her final narration, she reveals that she has dreams to be an actress and that a film studio might want to use her.
=== DNA === Forensic DNA analysis was first used in 1984. It was developed by Sir Alec Jeffreys, who realized that variation in the genetic sequence could be used to identify individuals and to tell individuals apart from one another. The first application of DNA profiles was used by Jeffreys in a double murder mystery in the small English town of Narborough, Leicestershire, in 1985. A 15-year-old school girl by the name of Lynda Mann was raped and murdered in Carlton Hayes psychiatric hospital. The police did not find a suspect but were able to obtain a semen sample. In 1986, Dawn Ashworth, 15 years old, was also raped and strangled in the nearby village of Enderby. Forensic evidence showed that both killers had the same blood type. Richard Buckland became the suspect because he worked at Carlton Hayes psychiatric hospital, had been spotted near Dawn Ashworth's murder scene and knew unreleased details about the body. He later confessed to Dawn's murder but not Lynda's. Jefferys was brought into the case to analyze the semen samples. He concluded that there was no match between the samples and Buckland, who became the first person to be exonerated using DNA. Jefferys confirmed that the DNA profiles were identical for the two murder semen samples. To find the perpetrator, DNA samples from the entire male population, more than 4,000 aged from 17 to 34, of the town were collected. They all were compared to semen samples from the crime. A friend of Colin Pitchfork was heard saying that he had given his sample to the police claiming to be Colin.
=== Playtesting === Valve playtests its games extensively from the beginning of development, and iterates based on the results. It believes that "all game designers are, in a sense, experimental psychologists". The Valve writer Chet Faliszek said he initially blamed testers when they failed to engage with designs as expected, but changed his mind when multiple testers had the same problem: "By the third or fourth time, all of a sudden you're realizing, 'I'm an idiot. This is pretty obvious this doesn't work. It's not their fault, it's our fault.'" He gave an example from the development of Left 4 Dead, wherein a texture change caused every tester to miss a ladder and become stuck. Walker said playtesting helped Valve maximize the experience for players. For example, when something exciting occurs by chance during a playtest, the developers attempt to have it occur for every player. Newell contrasted this approach to that of Warren Spector, whose open-ended games are designed to be replayed with different outcomes: "You spend all of this time to build stuff that most players will never ever ever see. ... If only one per cent of your customers see this cool thing that takes five per cent of your development budget, that's not a good use of resources."
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.